Although CaMKII is only one of many Ca2+-stimulated enzymes that are activated following ischemia, CaMKII appears to be one of the major upstream regulators in postischemia neurotoxicity because its inhibition can prevent the majority of infarct formation processes [34]. The gene discussed is CAMK2G; the disease is ischemia.